Literature DB >> 8251902

Differences between blastic chronic myeloid leukemia and Ph-positive acute leukemia.

R Berger1.   

Abstract

Cytogenetic and molecular characteristics of chronic myeloid leukemia in blast crisis and Ph-positive acute leukemia are compared. The main differences relate to the presence of Ph-negative metaphases at diagnosis and the disappearance of Ph in complete remission in acute leukemia, and the localization of the chromosome breakpoints in the BCR gene, in the bcr segment in chronic leukemia and in the first intron of the BCR gene in 50% of acute leukemias. The profiles of these abnormalities, as well as the types of additional chromosome changes, are not sufficient to distinguish between the two disorders in every patient. The distinction between these two entities, which is possible in the majority of patients, will be improved by results of experimental work currently in progress in many laboratories.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8251902     DOI: 10.3109/10428199309047892

Source DB:  PubMed          Journal:  Leuk Lymphoma        ISSN: 1026-8022


  10 in total

1.  Philadelphia chromosome-positive acute myeloid leukemia with masses and osteolytic lesions: finding of 18F-FDG PET/CT.

Authors:  Zhan Su; Fengyu Wu; Weiyu Hu; Xiaodan Liu; Shaoling Wu; Xianqi Feng; Zhongguang Cui; Jie Yang; Zhenguang Wang; Hongzai Guan; Hongguo Zhao; Wei Wang; Chunting Zhao; Jun Peng
Journal:  Front Med       Date:  2017-05-27       Impact factor: 4.592

2.  Molecular characterization of de novo Philadelphia chromosome-positive acute myeloid leukemia.

Authors:  Sergej Konoplev; C Cameron Yin; Steven M Kornblau; Hagop M Kantarjian; Marina Konopleva; Michael Andreeff; Gary Lu; Zhuang Zuo; Rajyalakshmi Luthra; L Jeffrey Medeiros; Carlos E Bueso-Ramos
Journal:  Leuk Lymphoma       Date:  2012-07-09

Review 3.  Molecular Classification and Overcoming Therapy Resistance for Acute Myeloid Leukemia with Adverse Genetic Factors.

Authors:  Daisuke Ikeda; SungGi Chi; Satoshi Uchiyama; Hirotaka Nakamura; Yong-Mei Guo; Nobuhiko Yamauchi; Junichiro Yuda; Yosuke Minami
Journal:  Int J Mol Sci       Date:  2022-05-25       Impact factor: 6.208

4.  A 75-year-old woman with thoracic spinal cord compression and chloroma (granulocytic sarcoma).

Authors:  Madhava Baikaidi; Stephen S Chung; Martin S Tallman; Lloyd E Damon; Alison R Walker; Guido Marcucci; Abdalla M Sholi; Gloria J Morris
Journal:  Semin Oncol       Date:  2012-12       Impact factor: 4.929

5.  Philadelphia chromosome with acute myeloid leukemia and concurrent large B cell lymphoma of different origins: A case report.

Authors:  Yang Dai; Xiao Shuai; Pu Kuang; Lin Wang; Ting Liu; Ting Niu
Journal:  Oncol Lett       Date:  2017-01-10       Impact factor: 2.967

6.  "Chronic myelogenous leukemia in primary blast crisis" rather than "de novo BCR-ABL1-positive acute myeloid leukemia".

Authors:  Cedric Pastoret; Roch Houot
Journal:  Clin Case Rep       Date:  2017-04-04

7.  Mixed phenotype acute leukemia with t(9;22): success with nonacute myeloid leukemia-type intensive induction therapy and stem cell transplantation.

Authors:  Onyee Chan; Abdur Rehman Jamil; Rebecca Millius; Ramandeep Kaur; Faiz Anwer
Journal:  Clin Case Rep       Date:  2017-02-26

8.  Isolated Ocular Manifestation of Relapsed Chronic Myelogenous Leukemia Presenting as Myeloid Blast Crisis in a Patient on Imatinib Therapy: A Case Report and Review of the Literature.

Authors:  Rohit Gulati; Yaser Alkhatib; Vijayalakshmi Donthireddy; Michelle Madden Felicella; Madhu P Menon; Kedar V Inamdar
Journal:  Case Rep Pathol       Date:  2015-12-24

9.  Erythroid blast crisis in chronic myelogenous leukemia: Case report and review of literature.

Authors:  Rochelle Nagales Nagamos; Teresa Gentile; Neerja Vajpayee
Journal:  Leuk Res Rep       Date:  2016-04-27

10.  Primary Philadelphia chromosome positive acute myeloid leukemia: A case report.

Authors:  Xiaoyan Shao; Dangui Chen; Peipei Xu; Miaoxin Peng; Chaoyang Guan; Pinhao Xie; Cuiying Yuan; Bing Chen
Journal:  Medicine (Baltimore)       Date:  2018-11       Impact factor: 1.817

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.